SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 5-Year Results and Correlative Analyses From ATEMPT (TBCRC033): Adjuvant Trastuzumab Emtansine vs. Paclitaxel + Trastuzumab for Stage I HER2+ BC
By
SABCS 2022 Conference Coverage
FEATURING
Paolo Tarantino
By
SABCS 2022 Conference Coverage
FEATURING
Paolo Tarantino
278 views
December 13, 2022
Comments 0
Login to view comments.
Click here to Login
Videos